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Abstract 
Background: At present, updated secondary implant stability data generated by actual versions of resonance fre-
quency analysis (RFA) and mobility measurement (MM) electronic devices of 2 different implant systems with 
actual manufactured surfaces seem to lack and/or are incomplete.
Material and Methods: Secondary implant stability data based on both RFA and MM measurements were collected 
and analyzed from 44 formerly treated patients (24 f, 20 m) that received either Ankylos Cellplus (Ø3.5mm) (A) 
(n=36) or  Straumann regular neck SLA tissue level (Ø4.1mm) (S) (n=37) implants in posterior positions of both 
jawbones (total number= 72). These results were interpretated in view of formerly published data. 
Results: Estimated RFA outcomes  (mean±SD) for A implants were of  81.23 (±0.65) (LP) - 76.15 (±1.57)  (UP) 
isq; for S implants 76.15 (±1.48) (LP) - 73.88 (±2.34) (UP) isq. Estimated MM outcomes for A implants were (-4.0) 
(±0.23) (LP) - (-3.2) (±0.33)  (UP) ptv; for S implants  (-5.15) (±0.39) (LP) - (-4.4) (±0.84) (UP) ptv. According to 
GEE statistical modelling, implant type and – position seems to influence the outcome variables (p<0.05), gender 
and implant length did not (p>0.05). 
Conclusions: Secondary implant stability values, recorded with current RFA and MM devices, of A Cellplus  im-
plants are provided for the first time.  A difference of 14.7-9.7 isq values was noted for CellPlus versus TPS  S 
implants recorded with a cabled RFA device. This study supports the assumption that RFA outcomes generated with 
first generation RFA devices are different from those obtained with current RFA devices, meaning that its use in 
reviews need caution and correction. 
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Introduction
The biologic process occuring during uneventful osseo-
integration of oral implants  follows a distinct and pre-
dictable biological pathway that has been demonstrated 
by several authors (1,2). Primary stability refers to the 
stability status of an implant immediately after insertion, 
whereas secondary stability refers to the stability status 
after completion of active osseointegration (3). Primary 
implant stability is a merely mechanical issue that is dic-
tated by factors such as bone density, surgical bed pre-
paration (under – or overpreparation), implant geometry 
(eg. cylindrical or tapered, non-self tapping or self tap-
ping), implant length and -  diameter (4-8). Subsequently, 
secondary stability is reached following the formation of 
new woven and lamellar bone onto the implant surface. 
With the advent and introduction of so-called ‘modera-
tely’ rough surfaces, shortening of the healing period to 
6-8 weeks was proposed for a the Straumann implant 
system specific implant system (9-11). Determination of 
implant stability makes part of several implant success 
criteria, both on long term (12) and short term (13,14). 
The latter author included to his set of success criteria al-
ready a notion of implant stability assessed by electronic 
devices as an alternative to manual tapping. 
While insertion torque recording devices, either analo-
gue or electronic, allow quantitative recording of a par-
ticular aspect of primary implant stability, RFA and MM 
recording devices are at present instruments  that allow 
monitoring of the implant stability evolution during the 
osseointegration period at a level that is not feasible 
with traditional clinical or radiographical methods (15). 
Both the RFA and MM procedures involve as common 
working principle, measurement of lateral displace-
ment and/or deflection of the implant in the surroun-
ding bone after controlled stimulus application. In case 
of the Periotest method, the excitation effect is induced 
by controlled mechanical tapping. From insertion untill 
prosthetic loading, a healing abutment can serve as the 
transducer for the tapping device force application  (16). 
RFA methdology is based on quantitative assessment of 
(micro)deflection of the implant induced by controlled 
appliance of electromagnetic excitation,  by aid as an 
implant system specific transducer (17,18).  Since the 
introduction of this technology, several generations of 
devices and transducers have been commercialized (19). 
The outcome of both RFA and MM methods is influen-
ced by multiple factors. The properties of the tranducer 
(eg. stiffness and screw properties) , the stiffness of the 
’implant-transducer’ complex , the  properties and  stiff-
ness of ‘implant-bone’ complex, eg. influenced by the 
effective heigth of the coronal implant part above the 
bone crest and the implant surface texture (19), and the 
stiffness of the bone itself are measurement influencing 
factors (20).  As both implant system surfaces and mea-
surement devices properties change over time, updating 
implant stability seems of value. Differences in implant 
stability between various generations of specific im-
plant systems with different surface characteristics are 
described (8-10). Besides, significant implant stability 
differences recorded by various generations of resonan-
ce frequency analysis (RFA) devices are published (21). 
Furthermore,  RFA and/or mobility measuring damping 
capacity (MM) based implant stability data of some ac-
tual surface textured implant systems for specific im-
plant diameters and/or positions are lacking. Objective 
measurement of secondary implant stability may allow 
the clinician to make the correct decision when to load 
an implant of a given type, and to make choices on a 
patient -to-patient basis as to the most advantageous 
protocol. To be able to do this, knowledge of values 
or value-ranges obtained by actual versions of the test 
devices after testing of actual implant that can serve as 
accepted normal outcomes and differences between va-
rious implant systems can be of help when interpretating 
individual implant measurements. At present, only a re-
port of Ankylos TPS surfaced implants is available ba-
sed on recordings by the previous cabled Osstell device 
(8). Furthermore, MM values for Straumann SLA surfa-
ced implants were apparently not found in the literature. 
The aims of this clinical retrospective study were: 1: 
to report secondary implant stability data of Ankylos 
Cell Plus  and Straumann tissue level SLA surfaced im-
plants implants recorded by the Osstell Mentor and the 
Periotest device, 2: to explore effects on the secondary 
implant stability outcome measurements of secondary 
variables, 3: to interpretate these results in view of 
previous reports. For both implant systems, data were 
retrieved from files of formerly treated patients from 
specific anatomical regions that received a specific im-
plant diameter for each implant system.
Material and Methods
-Patient selection
This retrospective cohort study was conducted in a pri-
vate periodontal practice.  Data were retrieved from files 
of formerly treated patients. These patients were referred 
for the surgical part of implant therapy by their general 
dentist. The choice of the applied implant system was 
made by the general dentist. No data concerning primary 
stability or bone quality were present for analysis. 
The following search criteria were adopted for case se-
lection:
• Implant system specifications: Ankylos Cell Plus 
implants with a diameter of 3.5mm (A) (Dentsply Im-
plants, Mannheim, Germany) or Straumann SLA tissue 
level RN with a diameter of 3.5mm.
• Transmucosal healing after implant insertion by aid of 
a healing abutment.
(A implants: Balance base posterior sulcus former , 3mm 
height (Dentsply Implants, Mannheim, Germany); S im-
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plants: Healing cap, 3mm height (Straumann AG, Basel, 
Switzerland))
• Insertion in posterior sites of the maxillary or mandi-
bular jaw bone
• No previous or concommitant bone augmentation pro-
cedures.
• Uneventfull healing in the period between insertion 
and time of measurement. 
• Normal clinical and radiographical aspects at the time 
of measurement. 
• Avalailability of both  RFA and MM data, recorded af-
ter a healing period of 8-12 weeks.
The search selection resulted in a a cohort of 44 formerly 
treated patients (22 females, 20 males) (mean age 56.2± 
12.3 years; range: 34-78 years) (Table 1). On implant 
level the cohort consisted of 73 implants (36 A implants, 
37 S implants)  with the following distribution:  upper 
posterior regions (UP):19 A and 18 S implants, lower 
posterior regions (LP): 17 A and 19 S implants. 
-Stability measurements
Implant stability data were collected after a mean hea-
ling period of approximately 8-10 weeks (A: LP: 8.7 ± 
4.2 weeks, UP: 10.0 ± 4.3 weeks; S: LP: 8.0 ± 1.3 weeks, 
UP: 9.6 ± 4.1 weeks). Differences between groups regar-
ding time of measurement were not significant different 
(data not shown). RFA measurements were performed on 
each implant at the implant level using a wireless type 
Osstell Mentor device (Osstell AB, Gothenburg, Swe-
den). An implant-specific transducer, called ‘Smartpeg’ 
(Osstell AB, Gothenburg,  Sweden) was used for each 
implant type. For A implants, Smartpeg type 13 was 
used. For S implants, Smartpeg type 4 was used. RFA 
data are reported in implant stability quotient units (isq), 
wherein greater positive values indicate greater stability. 
MM measurements were performed at healing abutment 
level using a Periotest device (Gulden, Modautal, Ger-
many). For both methodologies, measurements  were 
repeated until a constant value was obtained. The last 
(consistently obtained) value was used  for statistical 
analysis. 
-Statistical analysis
The SPSS statistical software package 22.0 (IBM SPSS, 
Chicago, USA) was used. As approximately 33% of the 
patients received multiple implants, ‘Generalized Esti-
mation Equation’ statistical modelling was applied. GEE 
was assumed to be appropriate to estimate parameters 
of a generalized linear model with a possible unknown 
correlation between outcomes (htpp://en.wikipedia.org/
wiki/Generalized_estimating_equation). Mean secon-
dary implant stability values were presented as estima-
tes according to the GEE modelling with standard errors 
and  95% confidence intervals (CI). The effects of gen-
der, implant type and implant length as dependent varia-
bles on the implant stability outcome was investigated 
after GEE modelling The null hypothesis of no effect  in 
outcome for various both patient and implant related de-
Outcome Implant 
type
Implant position
UJP LJP
RFA (isq) Ankylos
(n=36)
76.15(±1.48)
(73.07-79.96)
(n=19)
81.23 (±0.65)
(79.96-82.50)
(n=17)
Straumann
(n=37)
73.88 (±0.33)
(69.28-78.28)
(n=18)
76.15 (±1.48)
(73.04-79.27)
(n=19)
MM (ptv) Ankylos
(n=36)
-3.2 (±0.33)
(-3.8 ) - (-2.54)
(n=19)
-4.0 (±0.23)
(-4.4) - (-3.53)
(n=17)
Straumann
(n=37)
-4.4(±0.38)
(-5.1) - (-3.69)
(n=18)
-5.15 (±0.39)
(-5.9) - (-4.3)
(n=19)
Table 1: Secondary implant stability data mean (+/- SD) values and 95% CI’s according to im-
plant type and implant position.
A: Ankylos implant system, S: Straumann tissue level implant system; UP: upper jaw posterior 
position, LP: lower jaw posterior position, n: number, RFA: resonance frequency analysis, ISQ; 
implant stability quotient, MM: mobility measurement, PTV: Periotest values.
J Clin Exp Dent. 2017;9(9):e1121-8.                                                                                                                                           Secondary implant stability data of two implant systems
e1124
pendent variables was adopted. The level of significance 
was set at p = 0.05.
Results
-Subject and implant distribution descriptive data 
Most retrieved cases  received one (66.6 %) or two im-
plants (20 %), 6 patients received 3 or more implants 
(13,2%) (data not shown). Most of the A implants placed 
in UP positions had an intra-bony length of 11 mm, whe-
reas those placed in LP positions most commonly had an 
intra-bony length of 9.5 mm or 11 mm (data not shown). 
Most of the S implants placed in UP positions had an 
intra-bony length of 8 mm or 10 mm, whereas those pla-
ced in LP positions most commonly had an intra-bony 
length of 10 mm (data not shown). 
-Secondary implant stability outcome
Overall mean implant (±SD) and 95% CI’s of secondary 
stability data for both RFA and MM  testing of the two 
investigated implant implant systems are presented Ta-
ble 1. Both A and S implants exhibited higher and thus 
more favourable Osstell Mentor values in the mandible 
compared to the outcome in the maxilla. The same trend 
was observed for the MM outcomes for each implant 
system. According to the GEE modelling, a significant 
effect of implant position was observed on both RFA and 
MM outcomes  (Table 2). The effect of implant type was 
only significant on the RFA outcome, not on the MM 
outcome.  Gender, implant length and healing time had 
no effect on the RFA and MM outcomes. 
         Effect by method Wald 
Chi- square
            Significance (p-value)
RFA
Gender 0.252 0.616
Implant type 4.808 0.028*
Implant length 1.115 0.91
       Implant position 5.784 0.016*
Healing time 0.7950 0.372
MM
Gender 0.040 0.841
Implant type 3.602 0.058
Implant length 0.14 0.907
         Implant position 4.703 0.03*
Healing time 2.471 0.116
Table 2: Effects of gender, implant type, implant length, implant position and healing time on secondary implant 
stability measurements according to GEE modelling.
Discussion
In this study based on data retrospectively retrieved from 
patients referred for implant surgery, an attempt was 
made to report mean secondary implant stability values 
for two distinct implant types in two distinct areas of the 
oral cavity. All the implants were at the time of stability 
determination judged stable from a clinical and radio-
graphical point of view, as part of the search criteria. 
One diameter per implant system was chosen for each 
implant system in order to exclude any influence of the 
latter on outcome variarables within groups. Likewise, 
only one inter-arch location was included to exclude any 
influence of whithin –arch variation. Beside, all MM 
measurements were performed at healing abutments 
with 3mm heigth in order to exclude measurement 
errors derived from variable striking point heights from 
the bony crest. Since many patients received multiple 
implants, data analysis was performed using GEE mo-
delling to anticipate for possible unknown correlations 
between outcomes of multiple implants inserted in the 
same patient. Futhermore,  the influence of patient and 
implant related variables on both outcome variables was 
explored . 
As outlined in various guideline sets, the determination 
of implant stability or ‘implant immobility’ at various 
stages after implant insertion is considered of key im-
portance in therapeutic decision-making (13-15). Seve-
ral methodologies and/or tests to assess implant stability 
are described. Whereas some of them are applicable at 
RFA: resonance frequency analysis, MM: mobility measurement, GEE: Generalized Estimation Equation.
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multiple time-points after implant insertion, others has 
a more limited use, eg. determination of insertion tor-
que (22). Furthermore, the application of removal torque 
can be questioned from an ethical point of view (23,24). 
Electronic devices such as RFA and MM damping ca-
pacity recording instruments possess the power to de-
tect implant stability at the level that is not achieveable 
with traditional radiographical and/or clinical methods 
(3,14,15). For clinical application of both measurement 
systems, a transducer, meaning an implant system spe-
cific component, is needed to perform the measurement 
before prothetic loading: a healing abutment in case 
of MM and a Smartpeg in case of RFA. Both  electro-
nic devices applied in this retrospective study possess 
a substantial long time of use in implant dentistry. For 
Periotest, changes over time only apply to changes of 
the housing hardware and no changes to measurement 
technology, meaning that over time, outcomes of various 
generations of MM devices do not differ when applied to 
a given implant system in comparable conditions (http://
www.med-gulden.com). For Osstell RFA devices, chan-
ges over time do not only apply to the housing of the 
hardware but also to the intrinsic measurement techno-
logy but also to the data processing software (3). This 
means that differences of the application of various ge-
nerations of RFA devices to identical implant systems 
in comparable conditions are to expected. The original 
version of the Osstell RFA device consisted of a wired 
version of the transducer. The transducer consisted of 2 
built-in piezoceramic elements to be coupled to an in-
dividual implant, transmitting both the emitting signal 
and the captured evoked response. One piezoceramic 
element served as the transmittor element, receiving an 
electrically generated sine wave with varying frequency. 
The other piezoceramic element served as the receiver 
element capturing the induced vibrations in this spec-
trum and enabled a determination of resonance fre-
quencies of the investigated implant. A rather practical 
shortcoming of this version what the fact that measure-
ments had to be performed at 36 positions angled by 10° 
, thus covering a full spectrum of 360°. Meaning that 
the rather voluminous implant specific tranducer had to 
be (re)positioned every 10°. In this original approach 
the resonance frequency outcome was plotted against 
orientation. The response signal was analyzed by an os-
cilloscope with  the resonance frequency in kHz as the 
outcome unit. The launch of the  Osstell Mentor in 2004 
included the introduction of a less voluminous, much 
more user-friendly, non-cabled transducer, called ‘Smar-
tpeg’. Smartpegs are small aluminum rods with 3 diffe-
rent parts: a coronal part with an implant system specific 
screw fitting into the individual implant, a hexagon part 
enabling easy tightening / un-tightening and a magnet 
serving as the electromagnetic puls captor. The appa-
ratus itself was a compact device with an incorporated 
microcomputer and electromagnetic signal emitting and 
receiving tipped  probe. Excitation of the implant moun-
ted Smartpeg is performed by 4 electromagnetic pulses 
with different frequencies inducing Smartpeg vibration 
in mostly 2 directions perpendicular to each other. The 
vibration directions correspond to a low and a high reso-
nace frequency. The manufacturer recommends to per-
form at least 2 measurements, in order to identify these 
possible different stabilities. Furthermore, in order to 
suppress electromagnetic environmental noise, the wor-
king principle is refined by four times repeated emission 
of each excitation frequency. In summary, 16 pulses are 
emitted for each single measurements (20). The captured 
outcome of each in four fold emmitted signal is conver-
ted by the built-in microcomputer into a frequency spec-
trum by a ‘Fast Fourrier Transformation’ (FFT)  method, 
ending up to detect among the 4 calculated spectra the 
2 highest peaks representing the resonance frequencies 
of the implant. The latter will be used to calculate the 
so-called implant stability quotients (isq) by aid of a ma-
thematical algorithm, which is Osstell Company ‘house 
secret’. The isq output is a unitless number, ranging bet-
ween 0 and 100. 
The manufacturers of both Osstell and Periotest devices 
provide in the web retrieveable manual ranges of values 
to which individual implant stability outcomes can be 
compared.  In case of Periotest,  a guide of outcome va-
lues ranges is proposed (http://www.med-gulden.com). 
A range from  0 to -8 ptv indicate good osseointegration 
and allow for prosthetic loading. A range from +1 to +9 
indicate a warning that osseointegration might not be 
sufficient and a contra-indication for prosthetic loading. 
A range between +10 - +50 indicate clearly insufficient 
osseointegration and a contra-indication for loading. In 
case of Osstell, the listed isq ranges are the following: isq 
values <60 indicate an implant at risk, a range of 60-65 
isq calls for traditional loading, a range of 65-70 isq calls 
for early loading and implants exhibiting isq values >70 
isq can be cleared for immediate loading (http://www.
osstell.com/clinicalguidelines). In these guidelines, the 
RFA device manufacturer does not comment  how these 
ranges connect to a proper  generation of used RFA de-
vice nor if corrections for outcome values obtained by 
first generations RFA devices need to be made. Within 
the limits of this retrospective study, updated secondary 
implant stability data based on RFA and MM measure-
ments of different implant systems are reported. Accor-
ding to the GEE statistical modelling, implant type and 
– position seem to be influenced  the outcome variables 
(p<0.05), gender and implant length did not (p>0.05). 
When comparing the estimated secondary stability data 
based on RFA data reported in this retrospective study, 
the ranges of  A implants: 76.15 ±1.51 isq (UJP) – 81.23 
±0.65isq (LJP), and the S implants: 73.88 ±2.34 isq 
(UJP) – 76.15 ±1.48 isq (LJP), exceed by large the range 
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60-65 isq in case of traditional loading proposed in the 
Ostell guidelines. When comparing the secondary stabi-
lity data based on MM data reported in this retrospective 
study, the ranges of  A implants: -3.2 ± 0.33 ptv (UJP) 
–  -4.0 ±0.23 ptv (LJP), and the S implants: -4.4 ±0.38 
ptv (UJP) – -5.15 ±0.39 ptv (LJP), situate perfect in the 
range of 0 to -8  in case of traditional loading propo-
sed in the Gulden guidelines. To interpretate the present 
data, publications reporting implant secondary stability 
values for the presently described implant implant sys-
tems and surfaces were searched. Publications were whi-
thheld that provided short term longitudinal evolution of 
implant stability following insertion in posterior areas of 
the oral cavity with implant characteristics quite com-
parable to those in the present study (10,25-29). Surpri-
singly, detailed, prospective study information was only 
availaible for implant stability  analysed by RFA device 
for the Straumann implant system (Table 3) and not for 

Author & study implant
system 
implant
position
(implant
number) 
isq values at given 
time- points post-
insertion
type of Osstell device used
Barewal et al., 2003 
(25)
S 1.UJP (10) 
2.LJP (17) 
8W: 58
8W:
62.5 
wired Osstell
Bisschof et al., 2003 
(26)
S 3.UJP (54) 
4.LJP (36) 
12W:
57.1 
12W:
64.7 
wired Osstel
Huwiler et al., 2006 
(27)
S 5.UJP+LJP (17) 8W: 
62.8 
wired Osstell
Han et al., 2009 
(10)
S 6.LJP+LJP (10) 8W: 
75.2 
12W:
78.8 
Osstell Mentor
Bornstein et al., 2009 
(28)
S 7.LJP (56) 7W: 
81.1 
12W:
83.3 
Osstell Mentor
Guler et al., 2013 
(29)
S 8.UJP+LJP (108) 8W:
71.2 
Osstell Mentor
Rabel et al., 2005 
(3)
A 9.LJ + UJ (37) 0W: 
67.9 
12w:
Wired Osstell
Table 3: Published RFA based secondary implant stability data (mean values) for Straumann tissue level RN SLA surfaced implants 
(diameter=4.1mm) and Ankylos TPS surfaced implants (combined diameters).
A CellPlus textured implant system. Viceversa, MM de-
rived data were found only for the A implant (30,31) and 
not for the S implant system.
The estimated MM values in the present study for the 
Cell Plus textured A implant system, (-4.0) (±0.23) ptv 
(LP) - (-3.2) (±0.33) ptv  (UP), seem comparable with 
the reported ones for the TPS textured A system (30,31) 
(data not shown).
The estimated RFA outcomes for the Straumann im-
plants in the present study seems to be well in line with 
the results in the above mentioned studies (10,28,29). 
In these studies the wireless Osstell device was used to 
assess RFA based outcomes for Straumann tissue level 
implants with a diameter of 4.1mm. For combined UP 
and LP positions a range of 71.2 – 75.2 isq was noted 
after recording with the Osstell Mentor device after 8 
weeks (10,29), in one study (28) the come for LP posi-
tions was 81.1 isq after 7 weeks. In our study, an RFA 
outcome of 76,1 isq was noted for LP positions. When 
comparing the ranges of secondary implant stability of 
Straumann tissue level SLA Ø 4.1mm implants beween 
recording with the wired and wireless RFA device ver-
sions, a magnitude of difference of 8.4-18.6 isq units can 
be noted. According to the latter studies, in case of une-
ventfull healing of the Straumann system,  the ‘stability 
dip’ was consistently described between two and four 
weeks (10,28,29). Thus, single stability measurements 
after 8-12 weeks seem to be clinically meaningfull in 
the course of uneventfull healing during the osseointe-
gration period. In an in vitro approach (21), representing 
primary stability, compared the RFA outcome of MIS 
implants with diameters 3.75mm and 4.2mm (MIS Im-
plants Technologies Ltd., Shlomi, Israel),  inserted in ca-
daver jaw bone between the cabled Osstell device with 
the Osstell Mentor version. The mean outcome for the 
3.75mm Ø was 41.6 (±9) isq for the cabled version ver-
A: Ankylos implant system, S: Straumann tissue level implant system; UP: upper jaw posterior position, LJ: lower jaw – unspecified, UJ: 
upper jaw – unspecified, LPJ: lower jaw posterior position, UPP: upper jaw poesterior, SLA: sandblasted, large-grit, acid etched.
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sus 52.7 (±9) isq mm for the wireless version, indicating 
a difference of  11 isq. The mean outcome for the 4.2mm 
Ø was 50.9 (±9) isq for the cabled version versus 62.9 
(±7) isq for the wireless version, indicating a difference 
of 12 isq.  It can be concluded that for at least 3 implant 
systems, major and clinical important differences exist 
in outcome between cabled and non-cabled versions of 
Osstell devices. 
 To interpretate specifically the RFA based secondary 
implant stability data reported in this study for Cellplus 
A implants, the data provided in the only single report by 
Rabel et al. (8) were used for comparing.The investigated 
Ankylos implant type in this study concerned the origi-
nal commercialized Ankylos implant type characterized 
by a machined collar and a TPS surface. The currently 
available Ankylos implant type is characterisized by a 
moderately rough titanium surface along the full implant 
body without machined collar.   In this study, both pri-
mary and secondary implant stability values of 37 A TPS 
implants recorded by aid of the cabled version of the RFA 
device and an F 23 type wired transducer were analyzed. 
In this analysis however no clear description of implant 
diameter and/or insertion position was provided. For the 
total sample of 37 implants, a mean RFA outcome of 
primary implant stability of  67.9 isq and 66.5 isq for 
secondary implant stability was described (sd not provi-
ded). A particular finding in this study was the fact that 
the mean primary implant stability value was larger than 
the mean secondary stability value for this particular im-
plant system. The authors stated that this result could be 
explained that the insertion torque value for this non-self 
tapping implant system was extentively higher compa-
red to the other self tapping system analyzed in this par-
ticular study.  The RFA outcomes concerning secondary 
implant stability values of A CellPlus implants in this 
study ranged between 76.2 (±1.6) isq for UP positions 
and 81.2 (±1.6) isq for LP positions. When subtracting 
this estimates range  from the mean value provided by 
Rabel et al., a magnitude of difference range of 9.7-14.7 
isq values is obtained. 
Within the limits of this study, we assume that the outco-
mes reported for A CellPlus surfaced implants  may 
serve as a reference to which secondary implant stabi-
lity  outcomes of individual implants can be compared 
in conventional loading protocols after an uneventfull 
healing period of 8-12 weeks. Hereby,  implant type and 
– position seem to be influenced  the outcome variables 
(p<0.05), gender and implant length did not (p>0.05), 
(Table 4). 
Conclusions
When comparing the secondary implant stability outco-
me of A CellPlus implants reported values of A TPS im-
plants recorded by the cabled Osstell device, a difference 
of 9.7-14.7 isq values was noted. The magnitude of this 
difference is comparable with the described differences 
in clinical studies  for S tissue level implants  after recor-
ding with the cabled and wireless RFA devices and also 
for MIS implants in an in vitro experiment. The magni-
tude of the RFA outcome difference between both gene-
rations of the Osstell device is clinically significant. This 
implies that the use of data derived after recording with 
different generations of RFA devices in reviews should 
be done with caution and need for correction. 
Author & study remarks Implant specifications Implant position mean ptv (±SD)
Morris, 2000 (30) Ankylos TPS
surfaced implant
(machined collar)
Combined All sites
Baseline (6-8m post-
insertion): -3.1
9m post 2nd stage: -3.4
(n=457)
Romanos G,
2006 (31)
2 study groups: IL
versus DL
Ankylos, surface
unspecified
LJP IL group: 25m postload: -3.7
DL group: 25m postload: -3.2
Table 4: Published MM based secondary implant stability values (mean values) for Ankylos implants (combined diameters).
LJP: lower jaw posterior,  IL: immediate loading, DL: delayed loading, ptv: periotest values, TPS: titanium plasma spray, SLA: sandblasted, 
large-grit, acid-etched implant surface; RN: regular neck; UJP: upper jaw posterior; LJP: lower jaw posterior; L: implant length (mm); Ø: 
implant diameter (mm), isq: implant stability quotient, W: weeks.
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